Robin Van Bruggen

PI
Department of Molecular Hematology, Sanquin Research, Amsterdam, The Netherlands

Presentation(s):

• PB0185 - Exploring red blood cells as a novel tolerogenic approach for factor VIII inhibitors employing immuno-dominant FVIII derived peptides presented on MHC class II

  Sunday, July 10, 2022
  6:30 PM – 7:30 PM

• PB1272 - CRISPR-Based Knockout Red Blood Cells as Tools to Study Red Blood Cell Surface Protein Involvement in Thrombosis

  Tuesday, July 12, 2022
  6:30 PM – 7:30 PM